In two pancreatic adenocarcinoma xenografts, the mean frequency of CD24+ CD44+ ESA+ cells were 1.2% and 0.8%, consistent with the report by Li et al. as shown in Fig. 1A. This evidence concerns the gene CD44 and pancreatic adenocarcinoma.